| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |